[Raising HDL cholesterol: which is the best strategy?].
After having reached the objective for the LDL cholesterol levels, it becomes imperative to reach the objective for HDL cholesterol, known for its anti-atherogenic properties, generally confirmed in many epidemiological studies. This review deals, in a clear and concise manner, with the different alternatives available in daily clinical practice to raise the HDL cholesterol levels of patients, to achieve better outcomes in terms of morbidity and mortality in cardiovascular disease.
Alfonso
John Edwin Feliciano
JE
División de Lípidos y Diabetes, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. jefelicianoa@yahoo.com
Ariza
Iván Darío Sierra
ID
D002318:Cardiovascular Diseases / Q000378:metabolism / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism; D002995:Clofibric Acid / Q000627:therapeutic use; D015444:Exercise; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015201:Meta-Analysis as Topic; D009525:Niacin / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D000077285:Rimonabant; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D045162:Thiazolidinediones / Q000627:therapeutic use
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D010880:Piperidines; D011720:Pyrazoles; D045162:Thiazolidinediones; D009525:Niacin; D002995:Clofibric Acid; D000077285:Rimonabant